Mobaderi T, Kazemnejad A, Salehi M
BMC Infect Dis. 2025; 25(1):330.
PMID: 40065233
PMC: 11892175.
DOI: 10.1186/s12879-025-10715-x.
Keogh-Brown M, Sumner T, Sweeney S, Vassall A, Jensen H
PLoS Med. 2024; 21(12):e1004491.
PMID: 39666614
PMC: 11637336.
DOI: 10.1371/journal.pmed.1004491.
Arya R, Kumar S, Vinetz J, Kim J, Chaurasia R
Expert Rev Mol Med. 2024; 26:e32.
PMID: 39639643
PMC: 11629464.
DOI: 10.1017/erm.2024.29.
Sharew B, Berhan A, Almaw A, Erkihun M, Tiruneh T, Kiros T
J Clin Lab Anal. 2024; 38(22):e25111.
PMID: 39387506
PMC: 11584306.
DOI: 10.1002/jcla.25111.
Shi Z, Zhou L, Wang X, Zhang Z, Kong L, Zhang Y
Arch Microbiol. 2024; 206(8):352.
PMID: 39012499
DOI: 10.1007/s00203-024-04033-0.
Determinants of tuberculosis among adult people living with HIV on antiretroviral therapy at public hospitals in Hawassa City, South Ethiopia.
Asefa A, Bolka H, Markos Woldesemayat E
Front Epidemiol. 2024; 4:1353760.
PMID: 38638270
PMC: 11025533.
DOI: 10.3389/fepid.2024.1353760.
Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise.
Coussens A, Zaidi S, Allwood B, Dewan P, Gray G, Kohli M
Lancet Respir Med. 2024; 12(6):484-498.
PMID: 38527485
PMC: 7616323.
DOI: 10.1016/S2213-2600(24)00028-6.
Prevalence of Smear-Positive, Rifampicin-Resistant and Related Factors Among Residents with Cough in Northern Ethiopian Refugee Health Facilities.
Mezgebe H, Gebrecherkos T, Hagos D, Muthupandian S
Infect Drug Resist. 2024; 17:1135-1145.
PMID: 38525474
PMC: 10961074.
DOI: 10.2147/IDR.S453306.
Global prevalence, burden and trend in HIV and drug-susceptible tuberculosis co-infection from 1990 to 2019 and prediction to 2040.
Wang L, Lv H, Zhang X, Zhang X, Bai J, You S
Heliyon. 2024; 10(1):e23479.
PMID: 38205310
PMC: 10776929.
DOI: 10.1016/j.heliyon.2023.e23479.
The TB Surge intervention: an optimized approach to TB case-finding in Nigeria.
Ogoamaka C, Bethrand O, Lotanna U, Chidubem O, Sani U, Nkiru N
Public Health Action. 2023; 13(4):136-141.
PMID: 38077724
PMC: 10703131.
DOI: 10.5588/pha.23.0039.
Tuberculosis prevention, diagnosis, and treatment financial profile during 2006-2021: PART A.
Meskini M, Madadi N, Ahmadi K, Vaziri F, Fateh A, Siadat S
Cost Eff Resour Alloc. 2023; 21(1):68.
PMID: 37726829
PMC: 10507895.
DOI: 10.1186/s12962-023-00479-z.
Perspectives of healthcare and social support sector policymakers on potential solutions to mitigate financial impact among people with TB in Mozambique: a qualitative study.
Nhassengo P, Yoshino C, Zandamela A, De Carmo V, Burstrom B, Khosa C
BMJ Open. 2023; 13(8):e073234.
PMID: 37652592
PMC: 10476108.
DOI: 10.1136/bmjopen-2023-073234.
Treatment outcomes and associated factors among tuberculosis patients attending Gurage Zone Public Hospital, Southern Nations, Nationalities, and People's Region, Ethiopia: an institution-based cross-sectional study.
Agazhu H, Assefa Z, Beshir M, Tadesse H, Mengstie A
Front Med (Lausanne). 2023; 10:1105911.
PMID: 37601784
PMC: 10436196.
DOI: 10.3389/fmed.2023.1105911.
Predictors of mortality and survival probability distribution among patients on tuberculosis treatment in Vihiga County, Kenya.
Wekunda P, Omondi Aduda D, Guyah B, Odongo J
Afr Health Sci. 2023; 23(1):218-230.
PMID: 37545936
PMC: 10398452.
DOI: 10.4314/ahs.v23i1.24.
Tuberculosis Notification in Jordan, 2016-2020.
Khader Y, Abaza H, Satyanarayana S, Saleh Abu Rumman A, Alyousfi M
Epidemiologia (Basel). 2023; 4(3):276-285.
PMID: 37489499
PMC: 10366717.
DOI: 10.3390/epidemiologia4030028.
Trends in pulmonary tuberculosis mortality between 1985 and 2018: an observational analysis.
Singh H, Rupal A, Al Omari O, Jani C, Ahmed A, Khaliqdina S
BMC Pulm Med. 2023; 23(1):184.
PMID: 37237250
PMC: 10224609.
DOI: 10.1186/s12890-023-02458-9.
Effect of multicomponent interventions on tuberculosis notification in mining and pastoralist districts of Oromia region in Ethiopia: a longitudinal quasi-experimental study.
de Groot L, Dememew Z, Hiruy N, Datiko D, Gebreyes S, Suarez P
BMJ Open. 2023; 13(5):e071014.
PMID: 37188473
PMC: 10186083.
DOI: 10.1136/bmjopen-2022-071014.
An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management.
Chopra H, Mohanta Y, Ranjan Rauta P, Ahmed R, Mahanta S, Mishra P
Pharmaceuticals (Basel). 2023; 16(4).
PMID: 37111338
PMC: 10145450.
DOI: 10.3390/ph16040581.
Geographical evolutionary pathway of global tuberculosis incidence trends.
Lei Y, Wang J, Wang Y, Xu C
BMC Public Health. 2023; 23(1):755.
PMID: 37095497
PMC: 10123998.
DOI: 10.1186/s12889-023-15553-7.
Cost Effectiveness of a Shorter Moxifloxacin Based Regimen for Treating Drug Sensitive Tuberculosis in India.
Muniyandi M, Karikalan N, Velayutham B, Rajsekar K, Padmapriyadarsini C
Trop Med Infect Dis. 2022; 7(10).
PMID: 36288029
PMC: 9607110.
DOI: 10.3390/tropicalmed7100288.